Works in BMC Pharmacology & Toxicology, 2018, Vol 19, Issue 1


Results: 74
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.

    Published in:
    BMC Pharmacology & Toxicology, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s40360-018-0270-x
    By:
    • Ananthula, Hari Krishna;
    • Parker, Scott;
    • Touchette, Erin;
    • Buller, R. Mark;
    • Patel, Gopi;
    • Kalman, Daniel;
    • Salzer, Johanna S.;
    • Gallardo-Romero, Nadia;
    • Olson, Victoria;
    • Damon, Inger K.;
    • Moir-Savitz, Tessa;
    • Sallans, Larry;
    • Werner, Milton H.;
    • Sherwin, Catherine M.;
    • Desai, Pankaj B.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Lipid damage is the best marker of oxidative injury during the cardiac remodeling process induced by tobacco smoke.

    Published in:
    BMC Pharmacology & Toxicology, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s40360-018-0268-4
    By:
    • Lourenço, Maria Angélica Martins;
    • Braz, Mariana Gobbo;
    • Aun, Aline Garcia;
    • Pereira, Bruna Letícia Buzati;
    • Fernandes, Fábio Henrique;
    • Kazmarek, Elisa Moya;
    • Bachiega, Tatiana Fernanda;
    • Zanati, Silmeia Garcia;
    • Azevedo, Paula Schmidt;
    • Polegato, Bertha Furlan;
    • Fernandes, Ana Angélica Henrique;
    • de Paiva, Sergio Alberto Rupp;
    • Zornoff, Leonardo Antonio Mamede;
    • Minicucci, Marcos Ferreira
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50